157 related articles for article (PubMed ID: 20223589)
1. Peptide-mediated transdermal delivery of botulinum neurotoxin type A reduces neurogenic inflammation in the skin.
Carmichael NME; Dostrovsky JO; Charlton MP
Pain; 2010 May; 149(2):316-324. PubMed ID: 20223589
[TBL] [Abstract][Full Text] [Related]
2. Extracranial injections of botulinum neurotoxin type A inhibit intracranial meningeal nociceptors' responses to stimulation of TRPV1 and TRPA1 channels: Are we getting closer to solving this puzzle?
Zhang X; Strassman AM; Novack V; Brin MF; Burstein R
Cephalalgia; 2016 Aug; 36(9):875-86. PubMed ID: 26984967
[TBL] [Abstract][Full Text] [Related]
3. Minocycline inhibits the enhancement of antidromic primary afferent stimulation-evoked vasodilation following intradermal capsaicin injection.
Gong K; Yue Y; Zou X; Li D; Lin Q
Neurosci Lett; 2010 Sep; 482(2):177-81. PubMed ID: 20654697
[TBL] [Abstract][Full Text] [Related]
4. Botulinum Neurotoxin Chimeras Suppress Stimulation by Capsaicin of Rat Trigeminal Sensory Neurons In Vivo and In Vitro.
Antoniazzi C; Belinskaia M; Zurawski T; Kaza SK; Dolly JO; Lawrence GW
Toxins (Basel); 2022 Feb; 14(2):. PubMed ID: 35202143
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in inflammation evoked by noxious chemical, heat and electrical stimulation.
Carmichael NM; Charlton MP; Dostrovsky JO
Brain Res; 2009 Jun; 1276():103-11. PubMed ID: 19374887
[TBL] [Abstract][Full Text] [Related]
6. Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.
Krämer HH; Angerer C; Erbguth F; Schmelz M; Birklein F
J Neurol; 2003 Feb; 250(2):188-93. PubMed ID: 12574949
[TBL] [Abstract][Full Text] [Related]
7. Differential effect of Incobotulinumtoxin A on pain, neurogenic flare and hyperalgesia in human surrogate models of neurogenic pain.
Diener SA; Breimhorst M; Vogt T; Krämer HH; Drummond PD; Geber C; Birklein F
Eur J Pain; 2017 Sep; 21(8):1326-1335. PubMed ID: 28440002
[TBL] [Abstract][Full Text] [Related]
8. Involvement of capsaicin-sensitive afferents and the Transient Receptor Potential Vanilloid 1 Receptor in xylene-induced nocifensive behaviour and inflammation in the mouse.
Sándor K; Helyes Z; Elekes K; Szolcsányi J
Neurosci Lett; 2009 Feb; 451(3):204-7. PubMed ID: 19159661
[TBL] [Abstract][Full Text] [Related]
9. Botulinum toxin A does not alter capsaicin-induced pain perception in human skin.
Schulte-Mattler WJ; Opatz O; Blersch W; May A; Bigalke H; Wohlfahrt K
J Neurol Sci; 2007 Sep; 260(1-2):38-42. PubMed ID: 17481662
[TBL] [Abstract][Full Text] [Related]
10. Effect of pituitary adenylate cyclase activating polypeptide-38 on sensory neuropeptide release and neurogenic inflammation in rats and mice.
Németh J; Reglödi D; Pozsgai G; Szabó A; Elekes K; Pintér E; Szolcsányi J; Helyes Z
Neuroscience; 2006 Nov; 143(1):223-30. PubMed ID: 16938409
[TBL] [Abstract][Full Text] [Related]
11. Nociceptive neuroendocrine negative feedback control of neurogenic inflammation activated by capsaicin in the rat paw: role of the adrenal medulla.
Miao FJ; Janig W; Levine JD
J Physiol; 2000 Sep; 527 Pt 3(Pt 3):601-10. PubMed ID: 10990544
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type A selectivity for certain types of pain is associated with capsaicin-sensitive neurons.
Matak I; Rossetto O; Lacković Z
Pain; 2014 Aug; 155(8):1516-1526. PubMed ID: 24793910
[TBL] [Abstract][Full Text] [Related]
13. Activation of the 5-HT1B/D receptor reduces hindlimb neurogenic inflammation caused by sensory nerve stimulation and capsaicin.
Carmichael NM; Charlton MP; Dostrovsky JO
Pain; 2008 Jan; 134(1-2):97-105. PubMed ID: 17499925
[TBL] [Abstract][Full Text] [Related]
14. Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice.
Matak I; Tékus V; Bölcskei K; Lacković Z; Helyes Z
Neuroscience; 2017 Sep; 358():137-145. PubMed ID: 28673722
[TBL] [Abstract][Full Text] [Related]
15. Capsaicin-evoked CGRP release from rat buccal mucosa: development of a model system for studying trigeminal mechanisms of neurogenic inflammation.
Flores CM; Leong AS; Dussor GO; Harding-Rose C; Hargreaves KM; Kilo S
Eur J Neurosci; 2001 Oct; 14(7):1113-20. PubMed ID: 11683903
[TBL] [Abstract][Full Text] [Related]
16. Intra-articular injection of Botulinum toxin A reduces neurogenic inflammation in CFA-induced arthritic rat model.
Wang L; Wang K; Chu X; Li T; Shen N; Fan C; Niu Z; Zhang X; Hu L
Toxicon; 2017 Feb; 126():70-78. PubMed ID: 27838288
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain.
Cui M; Khanijou S; Rubino J; Aoki KR
Pain; 2004 Jan; 107(1-2):125-33. PubMed ID: 14715398
[TBL] [Abstract][Full Text] [Related]
18. Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy.
Filipović B; Matak I; Bach-Rojecky L; Lacković Z
PLoS One; 2012; 7(1):e29803. PubMed ID: 22238656
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin.
Gazerani P; Pedersen NS; Staahl C; Drewes AM; Arendt-Nielsen L
Pain; 2009 Jan; 141(1-2):60-9. PubMed ID: 19004549
[TBL] [Abstract][Full Text] [Related]
20. The effects of Botulinum Toxin type A on capsaicin-evoked pain, flare, and secondary hyperalgesia in an experimental human model of trigeminal sensitization.
Gazerani P; Staahl C; Drewes AM; Arendt-Nielsen L
Pain; 2006 Jun; 122(3):315-325. PubMed ID: 16677761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
